Raxibacumab
Active substance: raxibacumab
INJECTION · RAXIBACUMAB 50 mg/mL
United StatesActive
Marketing holder: Emergent BioDefense Operations Lansing
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- RAXIBACUMAB · 50 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1209b-f1bf-7ea9-a28d-c2d430b79473;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 71655-103
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 71655-103 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71655-103 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71655-103 · Verified 2026-10-09 · open in source